Michael Hacker

Prof. Dr. Michael Hacker

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2005 in Tissue Engineering
Verified
Journal Article
Closed access
MNMarkus Neubauer
Markus Neubauer
MHMichael Hacker
Michael Hacker
PBPetra Bauer-Kreisel
Petra Bauer-Kreisel
BWBarbara Weiser
Barbara Weiser
CFClaudia Fischbach
Claudia Fischbach
TBTorsten Blunk
Torsten Blunk
Despite the clinical need for reconstructive and plastic surgery, the supply of engineered adipose tissue equivalents still remains a challenge. As yet, only preadipocytes have been applied as a cell material for the in vitro tissue engineering of fat. Herein, we report the establishment of a three-dimensional (3-D) long-term cell culture, using bone marrow-derived mesenchymal stem cells (MSCs) as an alternative cell source and custom-made poly(lactic-co-glycolic acid) (PLGA) scaffolds as a cell carrier. Cell-polymer constructs were cultivated for 4 weeks in both the absence and presence of basic fibroblast growth factor (bFGF), which was previously shown to strongly enhance the adipogenesis of MSCs in conventional 2-D short-term culture. A striking enhancement of the adipogenic differentiation of MSCs and tissue development caused by bFGF in the 3-D culture was observed by osmium tetroxide histology and scanning electron microscopy. At the molecular level, reflecting the increased accumulation of lipids, bFGF increased the enzymatic activity of glycerol-3-phosphate dehydrogenase, a late marker of adipogenesis, and the expression of adipocyte-specific genes peroxisome proliferator activated receptor-gamma2 (PPARgamma2) and glucose transporter-4 (GLUT4), as assessed by reverse transcription-polymerase chain reaction. This study demonstrates that the use of bone marrow-derived MSCs, especially in combination with bFGF, may represent a promising approach to adipose tissue engineering.

1 May 2014 in Journal of Molecular Catalysis B: Enzymatic
Verified
Journal Article
Closed access
Ren WeiRen Wei
Ren Wei
TOThorsten Oeser
Thorsten Oeser
MBMarkus Barth
Markus Barth
NWNancy Weigl
Nancy Weigl
ALAnja Lübs
Anja Lübs
WZWolfgang Zimmermann
Wolfgang Zimmermann

1 October 2004 in Experimental Cell Research
Verified
Journal Article
Closed access
CFClaudia Fischbach
Claudia Fischbach
TSThilo Spruß
Thilo Spruß
BWBarbara Weiser
Barbara Weiser
MNMarkus Neubauer
Markus Neubauer
CBChristian Becker
Christian Becker
TBTorsten Blunk
Torsten Blunk

19 October 2004 in FEBS Letters
Verified
Journal Article
Closed access
MNMarkus Neubauer
Markus Neubauer
CFClaudia Fischbach
Claudia Fischbach
PBPetra Bauer-Kreisel
Petra Bauer-Kreisel
ELEsther Lieb
Esther Lieb
MHMichael Hacker
Michael Hacker
TBTorsten Blunk
Torsten Blunk

16 May 2008 in Biomacromolecules
Verified
Journal Article
Closed access
MHMichael Hacker
Michael Hacker
LKLeda Klouda
Leda Klouda
BMBrandy B. Ma
Brandy B. Ma
JKJames D. Kretlow
James D. Kretlow
AMAntonios G. Mikos
Antonios G. Mikos

1 February 2003 in Tissue Engineering
Verified
Journal Article
Closed access
ELE. Lieb
E. Lieb
JTJoerg Karl Volker Tessmar
Joerg Karl Volker Tessmar
MHMichael Hacker
Michael Hacker
CFC. Fischbach
C. Fischbach
DRD. Rose
D. Rose
MSMichaela Schulz-Siegmund
Michaela Schulz-Siegmund
Biodegradable polymers, such as poly(lactic acid) (PLA) and poly(lactic-coglycolic acid) (PLGA), are attractive materials for tissue engineering because of their degradative and mechanical properties, which permit scaffolds to be tailored to the individual requirements of different tissues. Although these materials support tissue development, their chemical properties offer no control of cell adhesion or function because their surfaces become immediately masked by adsorbing serum proteins when the materials come into contact with body fluids. Furthermore, adhesion proteins undergo conformational changes and a decrease in bioactivity when adsorbed to hydrophobic materials, such as PLA. To overcome these limitations, we modified the properties of PLA by synthesizing a diblock copolymer with poly(ethylene glycol) (PEG), which is known to reduce the amount of adsorbed proteins and to modify their conformation. By altering the PEG content of these diblock copolymers we were able to control the adsorption of adhesion proteins and, because cell adhesion takes place only in the presence of serum proteins, to control cell adhesion and cell shape. Marrow stromal cell differentiation to the osteoblastic phenotype was strongly improved on PEG-PLA compared with PLA, PLGA and tissue culture polystyrene and led to a 2-fold increase in alkaline phosphatase activity and mineralization.